Understanding our origin, purpose, and the principles that guide every medicine we create.

Hext Therapeutic Research Private Limited is an India-based pharmaceutical manufacturing and research organization committed to producing quality medicines for domestic government health programs, regulated export markets, and emerging economies.
The company's operating philosophy treats regulatory compliance not as a gate to pass but as an embedded scientific discipline — reflected in facility design, documentation systems, and product development pathways calibrated to Revised Schedule M, WHO Technical Report Series 986 (Annex 2 and Annex 3), and destination-country import requirements.
"To be a globally recognized pharmaceutical enterprise that makes scientifically validated, high-quality medicines accessible across regulated, emerging, and public-health markets."
These core values are embedded in every product, every partnership, and every process at HEXT Therapeutic Research Private Limited.
Scientific integrity in every formulation and clinical claim.
Uncompromising quality across the manufacturing lifecycle.
Regulatory transparency with importing-country authorities.
Equitable access to medicines regardless of market tier.
Building a pharmaceutical company that serves patients, respects communities, and safeguards the environment.
Hext integrates environmental and quality risk management into its manufacturing operations, consistent with the Quality Risk Management (QRM) principles embedded in Revised Schedule M, which extend beyond product quality into facility, utility, and computerized-systems governance.

Zero tolerance for falsified or substandard medicine practices.
Full pharmacovigilance reporting to CDSCO and relevant destination-market authorities.
Fair-pricing commitment for government and public-health-program supply contracts.
Data integrity governed by ALCOA+ principles across all quality records.
HEXT Therapeutic Research Private Limited is ready to support your medicine supply needs with science-backed quality and regulatory transparency.